Statera Biopharma, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Statera Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2022.
  • Statera Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was -$2.9M, a 234% decline year-over-year.
  • Statera Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $21M, a 269% increase from 2020.
  • Statera Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $5.68M.
  • Statera Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2018 was $55.2K.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 -$2.9M -$5.05M -234% Jan 1, 2022 Mar 31, 2022 10-Q 2022-10-21
Q1 2021 $2.16M +$1.77M +464% Jan 1, 2021 Mar 31, 2021 10-Q 2022-10-21
Q1 2020 $382K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2014 $6.34M +$6.35M Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-12
Q1 2013 -$17K +$3.52M +99.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 -$3.54M -$7.05M -201% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q1 2011 $3.51M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.